Head to Head Review: Hims & Hers Health (NYSE:HIMS) & Basel Medical Group (NASDAQ:BMGL)

Hims & Hers Health (NYSE:HIMSGet Free Report) and Basel Medical Group (NASDAQ:BMGLGet Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Volatility and Risk

Hims & Hers Health has a beta of 2.42, indicating that its share price is 142% more volatile than the S&P 500. Comparatively, Basel Medical Group has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Hims & Hers Health and Basel Medical Group, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health 1 11 4 0 2.19
Basel Medical Group 1 0 0 0 1.00

Hims & Hers Health presently has a consensus price target of $32.50, suggesting a potential upside of 17.22%. Given Hims & Hers Health’s stronger consensus rating and higher possible upside, equities analysts plainly believe Hims & Hers Health is more favorable than Basel Medical Group.

Insider & Institutional Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Hims & Hers Health and Basel Medical Group”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Hims & Hers Health $2.35 billion 2.76 $128.37 million ($0.63) -44.01
Basel Medical Group $8.90 million 0.85 -$9.50 million N/A N/A

Hims & Hers Health has higher revenue and earnings than Basel Medical Group.

Profitability

This table compares Hims & Hers Health and Basel Medical Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hims & Hers Health -5.51% -6.51% -1.20%
Basel Medical Group N/A N/A N/A

Summary

Hims & Hers Health beats Basel Medical Group on 9 of the 12 factors compared between the two stocks.

About Hims & Hers Health

(Get Free Report)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

About Basel Medical Group

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.